onlyTrustedInfo.comonlyTrustedInfo.comonlyTrustedInfo.com
Notification
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Reading: Diabetes Drug Mounjaro Could Be Game-Changer For Patients
Share
onlyTrustedInfo.comonlyTrustedInfo.com
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Search
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
  • Advertise
  • Advertise
© 2025 OnlyTrustedInfo.com . All Rights Reserved.
Life

Diabetes Drug Mounjaro Could Be Game-Changer For Patients

Last updated: April 7, 2025 3:19 am
Oliver James
Share
3 Min Read
Diabetes Drug Mounjaro Could Be Game-Changer For Patients
SHARE
Man with diabetes testing blood sugar
Dragana991/Getty Images
By Erin MarieMay 1, 2023 9:39 am EST

Results of Eli Lilly and Company’s second global phase 3 clinical trial named SURMOUNT-2 reveals that the drug tirzepatide, which goes by the brand name Mounjaro, could significantly improve the lives of those living with Type 2 diabetes. The research involved over 930 patients jointly diagnosed with obesity or overweight, as well as Type 2 diabetes.

“Obesity is a difficult-to-manage disease, and it’s even more difficult for people living with Type 2 diabetes,” said Dr. Jeff Emmick, senior vice president of product development at Eli Lilly in a public news release. While other drugs currently exist on the market to address obesity and overweight in patients with Type 2 diabetes, alternate research shows that Mounjaro may offer greater weight reduction outcomes than its existing counterpart, semaglutide, reports CBS News. 

In the recent trial, patients took either 10 or 15 milligrams of tirzepatide or a placebo. Those who took 10 milligrams of the drug saw an average weight reduction of nearly 30 pounds. Greater weight reduction was seen amongst patients who took the 15-milligram dose, with an average of 34.4 pounds lost. An average weight reduction of 7 pounds was observed in the placebo group.

Drug safety and side effects

Doctor measuring patient's blood sugar
Antonio_diaz/Getty Images

Furthermore, nearly 82% of participants in the 10-milligram intervention group experienced at least a 5% reduction in body weight. This number climbed to 86.4% among those who took 15 milligrams of tirzepatide. Only 30.5% of individuals in the placebo group experienced a 5% or more body weight reduction. Across the board, the drug also produced a drop in patient hemoglobin A1C levels, as outlined in the press release.

Among the side effects reported, the majority were mild to moderate cases of adverse gastrointestinal events. Yet the researchers noted more serious side effects are possible including the development of thyroid cancer, severe allergic reactions, pancreas inflammation, kidney failure, and gallbladder issues, amongst others. However, the safety profile across all clinical trial phases has proved consistent, which led the drug manufacturer to seek FDA approval on May 13, 2022.

Intended to be used as a supplement to diet and exercise, the once-weekly injection works by regulating a patient’s appetite, as well as how fat is used within the body. The drug is not designed for those with Type 1 diabetes nor for people under the age of 18.

You Might Also Like

Al Roker Recalls His Own Experience with Prostate Cancer as He Sends Well Wishes After Joe Biden’s Diagnosis

Coffee Or Energy Drinks: Which Drink Do People Reach For To Give Them Energy?

America’s 10 Most Deadliest Bodies of Water

What Happens to Your Body When You Eat Red Meat Every Day

Tribal Health Leaders Say Medicaid Cuts Would Decimate Health Programs

Share This Article
Facebook X Copy Link Print
Share
Previous Article Woman Left Paralyzed Neck Down From Rare Deficiency After Weight Loss Surgery Woman Left Paralyzed Neck Down From Rare Deficiency After Weight Loss Surgery
Next Article 5 RCB players in IPL 2025 who were earlier in MI ft. Tim David  5 RCB players in IPL 2025 who were earlier in MI ft. Tim David 

Latest News

EU unveils AI code of practice to help businesses comply with bloc’s rules
EU unveils AI code of practice to help businesses comply with bloc’s rules
Finance July 9, 2025
Nutella’s parent company Ferrero is buying cereal maker WK Kellogg for .1 billion
Nutella’s parent company Ferrero is buying cereal maker WK Kellogg for $3.1 billion
Finance July 9, 2025
Nvidia CEO Jensen Huang’s Net Worth Reaches 2 Billion, As Company Market Cap Sets Record
Nvidia CEO Jensen Huang’s Net Worth Reaches $142 Billion, As Company Market Cap Sets Record
Finance July 9, 2025
4 Best Investments To Earn Money in the Second Half of 2025
4 Best Investments To Earn Money in the Second Half of 2025
Finance July 9, 2025
//
  • About Us
  • Contact US
  • Privacy Policy
onlyTrustedInfo.comonlyTrustedInfo.com
© 2025 OnlyTrustedInfo.com . All Rights Reserved.